Relevium Launches the Push and Pull System™, Targeting a New Revenue Stream in the Burgeoning Cosmeceutical Market

CBJ Newsmakers

MONTREAL, Feb. 07, 2019 (GLOBE NEWSWIRE) — Relevium Technologies Inc. (TSX.V: “RLV”,  OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce the new launch of the Push and Pull System, an innovation in delivering a comprehensive solution for skin care, designed specifically for today’s active women.

THE FIRST EVER The Push and Pull System
The Push & Pull System™ by Bioganix® is the first ever comprehensive natural anti-aging system for complete skin care that combines Collagen Protein supplements (PUSH) and naturally sourced Aloe Vera skin anti-aging cream (PULL). This new launch is targeting a brand-new revenue stream in the burgeoning cosmeceutical market, which is the fastest growing segment of the health and wellness Market.

Relevium’s management has made the strategic decision to target Hispanic women initially in the US for its revolutionary Push and Pull System™. Hispanic women represent 17% of the female population in the US or 28 million. According to Nielsen Latina 2.0, Hispanic women are fiscally conscious, culturally influential and are the gatekeeper of the Familia Health. The same report explains that this segment of the US population is known to spend almost 4X as much as Caucasian American women in the health and beauty market.

Relevium is not the only company that believes this is an important market. According to Adage Facts 2018, last year advertisers in the US spent a staggering USD$9.2 billion marketing to 60 million Hispanics or 18% of the total population of the country. Furthermore, this is the fastest growing demographic segment in the US, and it is estimated that Hispanics will represent 30% of the population by 2050, almost doubling today’s numbers.

The Hispanic population in the US is a powerful consumer of advertising lead primarily by television followed by digital media and radio. As such, Relevium has decided to market Push and Pull System™ primarily through direct response Television and digital media, including social media.

The Company plans to launch its first direct response television campaign, followed by digital and social media in the first quarter of this year. As part of this campaign, the Company has retained Daniela Kosan, a Venezuelan beauty queen, TV presenter, mother and successful businesswoman to be the face of the unique Push and Pull System™.

Aurelio Useche, CEO stated “The launch of Push and Pull System™ in the fasted growing segment of the health and wellness market represents a major milestone for Relevium. The launch of the system in the US Hispanic market provides a focused and disciplined new approach to tailoring product offerings to customer needs of a potentially highly responsive market” Aurelio further commented “We believe with launching TV Commercials for this targeted market, this will help drive a lot value to the Bioganix brand and further increases our revenues”.

Abis Hussain CMO stated “The delivery of this new product bundle is tailored to the fastest growing demographic segment in the US, in which women are the major decision makers in terms of health and wellness for their families. In addition to Direct Response Television, our Company is building the supportive social media infrastructure to ensure the brand quickly gains trusted status in the target market”

To learn more about this new initiative, please join Aurelio Useche CEO, Abis Hussain CMO and Faycal Salek CFO at our upcoming shareholder web conference this Friday February 8, 2019 at 16:30. To register for this conference, please CLICK HERE.   

About Relevium Technologies

Relevium is a publicly-traded company that operates in the health and wellness industry, including legal cannabis, with a primary focus on online distribution. The principal business of the Company is the identification, evaluation, acquisition and operations of brands and businesses in the Health and Wellness markets and medical cannabis.

The Company pursues its business strategy through an acquisition and partnership model in a holistic approach to encompass a wide range of health and wellness consumer products. Relevium operates through two wholly-owned subsidiaries:

BGX E-Health LLC (BGX): Based in Orlando, Florida, BGX markets dietary supplements, nutraceuticals, sports nutrition and cosmeceuticals primarily through its Bioganix® brand portfolio in the US and Europe. Relevium’s brands such as Bioganix® are sold at some of the world’s largest retailers including such as and

The Company’s strategy for growing its brands includes expanding its product offering, adding new distribution channels and developing partnerships that add value through exclusive ingredients. BGX is currently testing a complete line of dietary supplements derived from Cannabis with an initial focus on hemp derived, whole plant organic extract rich in CBD (cannabidiol). The product line will be marketed through its brand LeefyLyfe® and will be sold first in Europe and then North America. The Company uses cannabinoids and ingredients that have achieved GRAS status (generally accepted as safe) to create brands that are sold via wholesale channels, retail channels and online distribution.

Biocannabix Health Corporation (BCX): Based in Montreal, Quebec, BCX is an entrepreneurial venture to establish a vertically integrated research based medical cannabis company in the Nutraceutical space.

Cautionary Note Regarding Forward-Looking Statements

This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. All statements in this news release, other than statements of historical facts, including statements regarding future estimates, plans, objectives, assumptions or expectations of future performance, including the timing and completion of the proposed acquisitions, are forward-looking statements and contain forward-looking information. Generally, forward- looking statements and information can be identified by the use of forward-looking terminology such as “intends” or “anticipates”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “should”, “would” or “occur”. Forward-looking statements are based on certain material assumptions and analysis made by the Company and the opinions and estimates of management as of the date of this press release. These forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements or forward-looking information. Important factors that may cause actual results to vary, include, without limitation, the risk that the proposed business developments may not occur as planned; the timing and receipt of requisite approvals and failure to raise sufficient funds.

Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward- looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial outlook that are incorporated by reference herein, except in accordance with applicable securities laws. We seek safe harbor.

On Behalf of the Board of Directors 


Aurelio Useche
Chief Executive Officer 

For more information about this press release: 


Tel: +1.888.528.8687
Email: [email protected]
Like us on Facebook
Follow us on Twitter
Follow us on LinkedIn